nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—coronary artery disease	0.113	1	CbGaD
Ceftriaxone—SLC15A2—Trandolapril—coronary artery disease	0.0528	0.0806	CbGbCtD
Ceftriaxone—SLC15A2—Perindopril—coronary artery disease	0.0483	0.0737	CbGbCtD
Ceftriaxone—SLC15A1—Trandolapril—coronary artery disease	0.0454	0.0694	CbGbCtD
Ceftriaxone—SLC15A1—Perindopril—coronary artery disease	0.0416	0.0635	CbGbCtD
Ceftriaxone—SLC15A2—Ramipril—coronary artery disease	0.04	0.0611	CbGbCtD
Ceftriaxone—SLC15A1—Enalapril—coronary artery disease	0.0344	0.0526	CbGbCtD
Ceftriaxone—SLC15A1—Lisinopril—coronary artery disease	0.0344	0.0526	CbGbCtD
Ceftriaxone—SLC15A1—Ramipril—coronary artery disease	0.0344	0.0526	CbGbCtD
Ceftriaxone—SLC22A11—Pravastatin—coronary artery disease	0.0331	0.0506	CbGbCtD
Ceftriaxone—SLC22A11—Furosemide—coronary artery disease	0.0282	0.043	CbGbCtD
Ceftriaxone—SLC22A8—Enalapril—coronary artery disease	0.0272	0.0416	CbGbCtD
Ceftriaxone—SLC15A1—Captopril—coronary artery disease	0.0258	0.0394	CbGbCtD
Ceftriaxone—SLC22A8—Pravastatin—coronary artery disease	0.0193	0.0294	CbGbCtD
Ceftriaxone—SLC22A6—Enalapril—coronary artery disease	0.019	0.029	CbGbCtD
Ceftriaxone—ALB—Pitavastatin—coronary artery disease	0.017	0.026	CbGbCtD
Ceftriaxone—ALB—Valsartan—coronary artery disease	0.0166	0.0253	CbGbCtD
Ceftriaxone—SLC22A8—Furosemide—coronary artery disease	0.0164	0.025	CbGbCtD
Ceftriaxone—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0144	0.022	CbGbCtD
Ceftriaxone—SLC22A6—Captopril—coronary artery disease	0.0142	0.0217	CbGbCtD
Ceftriaxone—SLC22A6—Pravastatin—coronary artery disease	0.0134	0.0205	CbGbCtD
Ceftriaxone—ALB—Rosuvastatin—coronary artery disease	0.0126	0.0192	CbGbCtD
Ceftriaxone—ALB—Acetylsalicylic acid—coronary artery disease	0.0122	0.0187	CbGbCtD
Ceftriaxone—ALB—Captopril—coronary artery disease	0.0121	0.0185	CbGbCtD
Ceftriaxone—SLC22A6—Furosemide—coronary artery disease	0.0114	0.0174	CbGbCtD
Ceftriaxone—SLC22A6—Losartan—coronary artery disease	0.0112	0.0171	CbGbCtD
Ceftriaxone—ALB—Furosemide—coronary artery disease	0.00972	0.0148	CbGbCtD
Ceftriaxone—ALB—Losartan—coronary artery disease	0.00953	0.0145	CbGbCtD
Ceftriaxone—Cefazolin—PON1—coronary artery disease	0.00065	0.393	CrCbGaD
Ceftriaxone—Cefdinir—MPO—coronary artery disease	0.000266	0.161	CrCbGaD
Ceftriaxone—Cefotetan—ALB—coronary artery disease	0.000197	0.119	CrCbGaD
Ceftriaxone—Cefpiramide—ALB—coronary artery disease	0.000172	0.104	CrCbGaD
Ceftriaxone—Cefonicid—ALB—coronary artery disease	0.000149	0.0903	CrCbGaD
Ceftriaxone—Flatulence—Lisinopril—coronary artery disease	9e-05	0.000534	CcSEcCtD
Ceftriaxone—Dyspepsia—Perindopril—coronary artery disease	8.99e-05	0.000534	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Enalapril—coronary artery disease	8.97e-05	0.000532	CcSEcCtD
Ceftriaxone—Abdominal pain—Pravastatin—coronary artery disease	8.97e-05	0.000532	CcSEcCtD
Ceftriaxone—Body temperature increased—Pravastatin—coronary artery disease	8.97e-05	0.000532	CcSEcCtD
Ceftriaxone—Dysgeusia—Lisinopril—coronary artery disease	8.94e-05	0.000531	CcSEcCtD
Ceftriaxone—Dizziness—Clopidogrel—coronary artery disease	8.93e-05	0.00053	CcSEcCtD
Ceftriaxone—Paraesthesia—Furosemide—coronary artery disease	8.92e-05	0.000529	CcSEcCtD
Ceftriaxone—Feeling abnormal—Telmisartan—coronary artery disease	8.92e-05	0.000529	CcSEcCtD
Ceftriaxone—Palpitations—Ramipril—coronary artery disease	8.9e-05	0.000528	CcSEcCtD
Ceftriaxone—Pruritus—Simvastatin—coronary artery disease	8.88e-05	0.000527	CcSEcCtD
Ceftriaxone—Dizziness—Lovastatin—coronary artery disease	8.87e-05	0.000526	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Telmisartan—coronary artery disease	8.85e-05	0.000525	CcSEcCtD
Ceftriaxone—Diarrhoea—Eplerenone—coronary artery disease	8.81e-05	0.000523	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—coronary artery disease	8.81e-05	0.0532	CrCbGaD
Ceftriaxone—Urticaria—Trandolapril—coronary artery disease	8.75e-05	0.000519	CcSEcCtD
Ceftriaxone—Pain—Perindopril—coronary artery disease	8.74e-05	0.000518	CcSEcCtD
Ceftriaxone—Vomiting—Fenofibrate—coronary artery disease	8.74e-05	0.000518	CcSEcCtD
Ceftriaxone—Hypersensitivity—Valsartan—coronary artery disease	8.73e-05	0.000518	CcSEcCtD
Ceftriaxone—Convulsion—Ramipril—coronary artery disease	8.72e-05	0.000518	CcSEcCtD
Ceftriaxone—Urticaria—Enalapril—coronary artery disease	8.72e-05	0.000517	CcSEcCtD
Ceftriaxone—Abdominal pain—Trandolapril—coronary artery disease	8.71e-05	0.000517	CcSEcCtD
Ceftriaxone—Body temperature increased—Trandolapril—coronary artery disease	8.71e-05	0.000517	CcSEcCtD
Ceftriaxone—Dizziness—Ezetimibe—coronary artery disease	8.7e-05	0.000516	CcSEcCtD
Ceftriaxone—Palpitations—Timolol—coronary artery disease	8.7e-05	0.000516	CcSEcCtD
Ceftriaxone—Abdominal pain—Enalapril—coronary artery disease	8.67e-05	0.000515	CcSEcCtD
Ceftriaxone—Body temperature increased—Enalapril—coronary artery disease	8.67e-05	0.000515	CcSEcCtD
Ceftriaxone—Feeling abnormal—Captopril—coronary artery disease	8.67e-05	0.000515	CcSEcCtD
Ceftriaxone—Rash—Fenofibrate—coronary artery disease	8.66e-05	0.000514	CcSEcCtD
Ceftriaxone—Dermatitis—Fenofibrate—coronary artery disease	8.66e-05	0.000514	CcSEcCtD
Ceftriaxone—Headache—Fenofibrate—coronary artery disease	8.61e-05	0.000511	CcSEcCtD
Ceftriaxone—Paraesthesia—Losartan—coronary artery disease	8.61e-05	0.000511	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Captopril—coronary artery disease	8.61e-05	0.000511	CcSEcCtD
Ceftriaxone—Urticaria—Telmisartan—coronary artery disease	8.6e-05	0.00051	CcSEcCtD
Ceftriaxone—Vomiting—Clopidogrel—coronary artery disease	8.59e-05	0.000509	CcSEcCtD
Ceftriaxone—Diarrhoea—Simvastatin—coronary artery disease	8.59e-05	0.000509	CcSEcCtD
Ceftriaxone—Body temperature increased—Telmisartan—coronary artery disease	8.56e-05	0.000508	CcSEcCtD
Ceftriaxone—Abdominal pain—Telmisartan—coronary artery disease	8.56e-05	0.000508	CcSEcCtD
Ceftriaxone—Vomiting—Lovastatin—coronary artery disease	8.53e-05	0.000506	CcSEcCtD
Ceftriaxone—Dizziness—Eplerenone—coronary artery disease	8.52e-05	0.000505	CcSEcCtD
Ceftriaxone—Rash—Clopidogrel—coronary artery disease	8.52e-05	0.000505	CcSEcCtD
Ceftriaxone—Dermatitis—Clopidogrel—coronary artery disease	8.51e-05	0.000505	CcSEcCtD
Ceftriaxone—Pain—Furosemide—coronary artery disease	8.49e-05	0.000504	CcSEcCtD
Ceftriaxone—Hypersensitivity—Niacin—coronary artery disease	8.49e-05	0.000504	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Lisinopril—coronary artery disease	8.47e-05	0.000503	CcSEcCtD
Ceftriaxone—Discomfort—Ramipril—coronary artery disease	8.47e-05	0.000503	CcSEcCtD
Ceftriaxone—Headache—Clopidogrel—coronary artery disease	8.46e-05	0.000502	CcSEcCtD
Ceftriaxone—Rash—Lovastatin—coronary artery disease	8.46e-05	0.000502	CcSEcCtD
Ceftriaxone—Dermatitis—Lovastatin—coronary artery disease	8.45e-05	0.000501	CcSEcCtD
Ceftriaxone—Anaemia—Lisinopril—coronary artery disease	8.44e-05	0.000501	CcSEcCtD
Ceftriaxone—Dyspepsia—Losartan—coronary artery disease	8.44e-05	0.000501	CcSEcCtD
Ceftriaxone—Feeling abnormal—Perindopril—coronary artery disease	8.42e-05	0.0005	CcSEcCtD
Ceftriaxone—Headache—Lovastatin—coronary artery disease	8.4e-05	0.000499	CcSEcCtD
Ceftriaxone—Pruritus—Valsartan—coronary artery disease	8.38e-05	0.000497	CcSEcCtD
Ceftriaxone—Vomiting—Ezetimibe—coronary artery disease	8.37e-05	0.000496	CcSEcCtD
Ceftriaxone—Hypersensitivity—Pravastatin—coronary artery disease	8.36e-05	0.000496	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Perindopril—coronary artery disease	8.36e-05	0.000496	CcSEcCtD
Ceftriaxone—Pruritus—Olmesartan—coronary artery disease	8.34e-05	0.000495	CcSEcCtD
Ceftriaxone—Body temperature increased—Captopril—coronary artery disease	8.32e-05	0.000494	CcSEcCtD
Ceftriaxone—Abdominal pain—Captopril—coronary artery disease	8.32e-05	0.000494	CcSEcCtD
Ceftriaxone—Dizziness—Simvastatin—coronary artery disease	8.3e-05	0.000492	CcSEcCtD
Ceftriaxone—Rash—Ezetimibe—coronary artery disease	8.3e-05	0.000492	CcSEcCtD
Ceftriaxone—Dermatitis—Ezetimibe—coronary artery disease	8.29e-05	0.000492	CcSEcCtD
Ceftriaxone—Discomfort—Timolol—coronary artery disease	8.28e-05	0.000491	CcSEcCtD
Ceftriaxone—Headache—Ezetimibe—coronary artery disease	8.24e-05	0.000489	CcSEcCtD
Ceftriaxone—Malaise—Lisinopril—coronary artery disease	8.24e-05	0.000489	CcSEcCtD
Ceftriaxone—Oedema—Ramipril—coronary artery disease	8.22e-05	0.000488	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Ramipril—coronary artery disease	8.22e-05	0.000488	CcSEcCtD
Ceftriaxone—Pain—Losartan—coronary artery disease	8.2e-05	0.000486	CcSEcCtD
Ceftriaxone—Vomiting—Eplerenone—coronary artery disease	8.19e-05	0.000486	CcSEcCtD
Ceftriaxone—Feeling abnormal—Furosemide—coronary artery disease	8.19e-05	0.000486	CcSEcCtD
Ceftriaxone—Leukopenia—Lisinopril—coronary artery disease	8.17e-05	0.000485	CcSEcCtD
Ceftriaxone—Nausea—Fenofibrate—coronary artery disease	8.16e-05	0.000484	CcSEcCtD
Ceftriaxone—Pruritus—Niacin—coronary artery disease	8.15e-05	0.000484	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Furosemide—coronary artery disease	8.12e-05	0.000482	CcSEcCtD
Ceftriaxone—Rash—Eplerenone—coronary artery disease	8.12e-05	0.000482	CcSEcCtD
Ceftriaxone—Urticaria—Perindopril—coronary artery disease	8.12e-05	0.000482	CcSEcCtD
Ceftriaxone—Hypersensitivity—Trandolapril—coronary artery disease	8.12e-05	0.000482	CcSEcCtD
Ceftriaxone—Dermatitis—Eplerenone—coronary artery disease	8.11e-05	0.000481	CcSEcCtD
Ceftriaxone—Diarrhoea—Valsartan—coronary artery disease	8.11e-05	0.000481	CcSEcCtD
Ceftriaxone—Hypersensitivity—Enalapril—coronary artery disease	8.08e-05	0.00048	CcSEcCtD
Ceftriaxone—Abdominal pain—Perindopril—coronary artery disease	8.08e-05	0.000479	CcSEcCtD
Ceftriaxone—Body temperature increased—Perindopril—coronary artery disease	8.08e-05	0.000479	CcSEcCtD
Ceftriaxone—Palpitations—Lisinopril—coronary artery disease	8.07e-05	0.000479	CcSEcCtD
Ceftriaxone—Diarrhoea—Olmesartan—coronary artery disease	8.07e-05	0.000479	CcSEcCtD
Ceftriaxone—Headache—Eplerenone—coronary artery disease	8.07e-05	0.000479	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Ramipril—coronary artery disease	8.05e-05	0.000477	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Timolol—coronary artery disease	8.03e-05	0.000477	CcSEcCtD
Ceftriaxone—Oedema—Timolol—coronary artery disease	8.03e-05	0.000477	CcSEcCtD
Ceftriaxone—Pruritus—Pravastatin—coronary artery disease	8.03e-05	0.000476	CcSEcCtD
Ceftriaxone—Nausea—Clopidogrel—coronary artery disease	8.02e-05	0.000476	CcSEcCtD
Ceftriaxone—Infection—Timolol—coronary artery disease	7.98e-05	0.000474	CcSEcCtD
Ceftriaxone—Vomiting—Simvastatin—coronary artery disease	7.98e-05	0.000473	CcSEcCtD
Ceftriaxone—Hypersensitivity—Telmisartan—coronary artery disease	7.97e-05	0.000473	CcSEcCtD
Ceftriaxone—Nausea—Lovastatin—coronary artery disease	7.97e-05	0.000473	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Ramipril—coronary artery disease	7.94e-05	0.000471	CcSEcCtD
Ceftriaxone—Rash—Simvastatin—coronary artery disease	7.91e-05	0.000469	CcSEcCtD
Ceftriaxone—Dermatitis—Simvastatin—coronary artery disease	7.9e-05	0.000469	CcSEcCtD
Ceftriaxone—Feeling abnormal—Losartan—coronary artery disease	7.9e-05	0.000469	CcSEcCtD
Ceftriaxone—Urticaria—Furosemide—coronary artery disease	7.89e-05	0.000468	CcSEcCtD
Ceftriaxone—Diarrhoea—Niacin—coronary artery disease	7.88e-05	0.000468	CcSEcCtD
Ceftriaxone—Headache—Simvastatin—coronary artery disease	7.86e-05	0.000466	CcSEcCtD
Ceftriaxone—Abdominal pain—Furosemide—coronary artery disease	7.85e-05	0.000466	CcSEcCtD
Ceftriaxone—Body temperature increased—Furosemide—coronary artery disease	7.85e-05	0.000466	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Losartan—coronary artery disease	7.84e-05	0.000465	CcSEcCtD
Ceftriaxone—Dizziness—Valsartan—coronary artery disease	7.84e-05	0.000465	CcSEcCtD
Ceftriaxone—Nausea—Ezetimibe—coronary artery disease	7.82e-05	0.000464	CcSEcCtD
Ceftriaxone—Dizziness—Olmesartan—coronary artery disease	7.8e-05	0.000463	CcSEcCtD
Ceftriaxone—Pruritus—Trandolapril—coronary artery disease	7.79e-05	0.000462	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Timolol—coronary artery disease	7.77e-05	0.000461	CcSEcCtD
Ceftriaxone—Pruritus—Enalapril—coronary artery disease	7.76e-05	0.000461	CcSEcCtD
Ceftriaxone—Diarrhoea—Pravastatin—coronary artery disease	7.76e-05	0.000461	CcSEcCtD
Ceftriaxone—Discomfort—Lisinopril—coronary artery disease	7.68e-05	0.000456	CcSEcCtD
Ceftriaxone—Pruritus—Telmisartan—coronary artery disease	7.66e-05	0.000454	CcSEcCtD
Ceftriaxone—Nausea—Eplerenone—coronary artery disease	7.65e-05	0.000454	CcSEcCtD
Ceftriaxone—Dizziness—Niacin—coronary artery disease	7.62e-05	0.000452	CcSEcCtD
Ceftriaxone—Urticaria—Losartan—coronary artery disease	7.61e-05	0.000452	CcSEcCtD
Ceftriaxone—Abdominal pain—Losartan—coronary artery disease	7.58e-05	0.00045	CcSEcCtD
Ceftriaxone—Body temperature increased—Losartan—coronary artery disease	7.58e-05	0.00045	CcSEcCtD
Ceftriaxone—Diarrhoea—Trandolapril—coronary artery disease	7.54e-05	0.000447	CcSEcCtD
Ceftriaxone—Vomiting—Valsartan—coronary artery disease	7.53e-05	0.000447	CcSEcCtD
Ceftriaxone—Diarrhoea—Enalapril—coronary artery disease	7.51e-05	0.000445	CcSEcCtD
Ceftriaxone—Dizziness—Pravastatin—coronary artery disease	7.5e-05	0.000445	CcSEcCtD
Ceftriaxone—Vomiting—Olmesartan—coronary artery disease	7.5e-05	0.000445	CcSEcCtD
Ceftriaxone—Rash—Valsartan—coronary artery disease	7.47e-05	0.000443	CcSEcCtD
Ceftriaxone—Dermatitis—Valsartan—coronary artery disease	7.47e-05	0.000443	CcSEcCtD
Ceftriaxone—Nausea—Simvastatin—coronary artery disease	7.45e-05	0.000442	CcSEcCtD
Ceftriaxone—Oedema—Lisinopril—coronary artery disease	7.45e-05	0.000442	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Lisinopril—coronary artery disease	7.45e-05	0.000442	CcSEcCtD
Ceftriaxone—Pruritus—Captopril—coronary artery disease	7.45e-05	0.000442	CcSEcCtD
Ceftriaxone—Rash—Olmesartan—coronary artery disease	7.44e-05	0.000441	CcSEcCtD
Ceftriaxone—Dermatitis—Olmesartan—coronary artery disease	7.43e-05	0.000441	CcSEcCtD
Ceftriaxone—Headache—Valsartan—coronary artery disease	7.42e-05	0.00044	CcSEcCtD
Ceftriaxone—Diarrhoea—Telmisartan—coronary artery disease	7.41e-05	0.000439	CcSEcCtD
Ceftriaxone—Infection—Lisinopril—coronary artery disease	7.4e-05	0.000439	CcSEcCtD
Ceftriaxone—Headache—Olmesartan—coronary artery disease	7.39e-05	0.000438	CcSEcCtD
Ceftriaxone—Paraesthesia—Ramipril—coronary artery disease	7.38e-05	0.000438	CcSEcCtD
Ceftriaxone—Vomiting—Niacin—coronary artery disease	7.33e-05	0.000435	CcSEcCtD
Ceftriaxone—Hypersensitivity—Furosemide—coronary artery disease	7.32e-05	0.000434	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Lisinopril—coronary artery disease	7.3e-05	0.000433	CcSEcCtD
Ceftriaxone—Dizziness—Trandolapril—coronary artery disease	7.29e-05	0.000432	CcSEcCtD
Ceftriaxone—Rash—Niacin—coronary artery disease	7.27e-05	0.000431	CcSEcCtD
Ceftriaxone—Dermatitis—Niacin—coronary artery disease	7.26e-05	0.000431	CcSEcCtD
Ceftriaxone—Dizziness—Enalapril—coronary artery disease	7.26e-05	0.000431	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—coronary artery disease	7.24e-05	0.0437	CrCbGaD
Ceftriaxone—Dyspepsia—Ramipril—coronary artery disease	7.23e-05	0.000429	CcSEcCtD
Ceftriaxone—Pruritus—Perindopril—coronary artery disease	7.23e-05	0.000429	CcSEcCtD
Ceftriaxone—Headache—Niacin—coronary artery disease	7.22e-05	0.000428	CcSEcCtD
Ceftriaxone—Paraesthesia—Timolol—coronary artery disease	7.21e-05	0.000428	CcSEcCtD
Ceftriaxone—Vomiting—Pravastatin—coronary artery disease	7.21e-05	0.000428	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Lisinopril—coronary artery disease	7.21e-05	0.000427	CcSEcCtD
Ceftriaxone—Diarrhoea—Captopril—coronary artery disease	7.2e-05	0.000427	CcSEcCtD
Ceftriaxone—Dizziness—Telmisartan—coronary artery disease	7.16e-05	0.000425	CcSEcCtD
Ceftriaxone—Rash—Pravastatin—coronary artery disease	7.15e-05	0.000424	CcSEcCtD
Ceftriaxone—Dermatitis—Pravastatin—coronary artery disease	7.15e-05	0.000424	CcSEcCtD
Ceftriaxone—Headache—Pravastatin—coronary artery disease	7.11e-05	0.000422	CcSEcCtD
Ceftriaxone—Dyspepsia—Timolol—coronary artery disease	7.07e-05	0.00042	CcSEcCtD
Ceftriaxone—Hypersensitivity—Losartan—coronary artery disease	7.06e-05	0.000419	CcSEcCtD
Ceftriaxone—Nausea—Valsartan—coronary artery disease	7.04e-05	0.000418	CcSEcCtD
Ceftriaxone—Pruritus—Furosemide—coronary artery disease	7.03e-05	0.000417	CcSEcCtD
Ceftriaxone—Nausea—Olmesartan—coronary artery disease	7.01e-05	0.000416	CcSEcCtD
Ceftriaxone—Vomiting—Trandolapril—coronary artery disease	7e-05	0.000416	CcSEcCtD
Ceftriaxone—Diarrhoea—Perindopril—coronary artery disease	6.99e-05	0.000415	CcSEcCtD
Ceftriaxone—Vomiting—Enalapril—coronary artery disease	6.98e-05	0.000414	CcSEcCtD
Ceftriaxone—Dizziness—Captopril—coronary artery disease	6.96e-05	0.000413	CcSEcCtD
Ceftriaxone—Rash—Trandolapril—coronary artery disease	6.95e-05	0.000412	CcSEcCtD
Ceftriaxone—Dermatitis—Trandolapril—coronary artery disease	6.94e-05	0.000412	CcSEcCtD
Ceftriaxone—Rash—Enalapril—coronary artery disease	6.92e-05	0.00041	CcSEcCtD
Ceftriaxone—Dermatitis—Enalapril—coronary artery disease	6.91e-05	0.00041	CcSEcCtD
Ceftriaxone—Headache—Trandolapril—coronary artery disease	6.9e-05	0.000409	CcSEcCtD
Ceftriaxone—Vomiting—Telmisartan—coronary artery disease	6.88e-05	0.000408	CcSEcCtD
Ceftriaxone—Headache—Enalapril—coronary artery disease	6.87e-05	0.000408	CcSEcCtD
Ceftriaxone—Pain—Timolol—coronary artery disease	6.87e-05	0.000408	CcSEcCtD
Ceftriaxone—Nausea—Niacin—coronary artery disease	6.84e-05	0.000406	CcSEcCtD
Ceftriaxone—Rash—Telmisartan—coronary artery disease	6.82e-05	0.000405	CcSEcCtD
Ceftriaxone—Dermatitis—Telmisartan—coronary artery disease	6.82e-05	0.000404	CcSEcCtD
Ceftriaxone—Diarrhoea—Furosemide—coronary artery disease	6.8e-05	0.000403	CcSEcCtD
Ceftriaxone—Pruritus—Losartan—coronary artery disease	6.78e-05	0.000402	CcSEcCtD
Ceftriaxone—Headache—Telmisartan—coronary artery disease	6.78e-05	0.000402	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ramipril—coronary artery disease	6.77e-05	0.000402	CcSEcCtD
Ceftriaxone—Dizziness—Perindopril—coronary artery disease	6.76e-05	0.000401	CcSEcCtD
Ceftriaxone—Nausea—Pravastatin—coronary artery disease	6.74e-05	0.0004	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ramipril—coronary artery disease	6.72e-05	0.000399	CcSEcCtD
Ceftriaxone—Paraesthesia—Lisinopril—coronary artery disease	6.69e-05	0.000397	CcSEcCtD
Ceftriaxone—Vomiting—Captopril—coronary artery disease	6.69e-05	0.000397	CcSEcCtD
Ceftriaxone—Rash—Captopril—coronary artery disease	6.64e-05	0.000394	CcSEcCtD
Ceftriaxone—Dermatitis—Captopril—coronary artery disease	6.63e-05	0.000393	CcSEcCtD
Ceftriaxone—Feeling abnormal—Timolol—coronary artery disease	6.62e-05	0.000393	CcSEcCtD
Ceftriaxone—Headache—Captopril—coronary artery disease	6.59e-05	0.000391	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Timolol—coronary artery disease	6.57e-05	0.00039	CcSEcCtD
Ceftriaxone—Dizziness—Furosemide—coronary artery disease	6.57e-05	0.00039	CcSEcCtD
Ceftriaxone—Dyspepsia—Lisinopril—coronary artery disease	6.56e-05	0.000389	CcSEcCtD
Ceftriaxone—Diarrhoea—Losartan—coronary artery disease	6.56e-05	0.000389	CcSEcCtD
Ceftriaxone—Nausea—Trandolapril—coronary artery disease	6.54e-05	0.000388	CcSEcCtD
Ceftriaxone—Urticaria—Ramipril—coronary artery disease	6.53e-05	0.000387	CcSEcCtD
Ceftriaxone—Nausea—Enalapril—coronary artery disease	6.52e-05	0.000387	CcSEcCtD
Ceftriaxone—Vomiting—Perindopril—coronary artery disease	6.5e-05	0.000385	CcSEcCtD
Ceftriaxone—Abdominal pain—Ramipril—coronary artery disease	6.5e-05	0.000385	CcSEcCtD
Ceftriaxone—Body temperature increased—Ramipril—coronary artery disease	6.5e-05	0.000385	CcSEcCtD
Ceftriaxone—Rash—Perindopril—coronary artery disease	6.44e-05	0.000382	CcSEcCtD
Ceftriaxone—Dermatitis—Perindopril—coronary artery disease	6.44e-05	0.000382	CcSEcCtD
Ceftriaxone—Nausea—Telmisartan—coronary artery disease	6.43e-05	0.000381	CcSEcCtD
Ceftriaxone—Headache—Perindopril—coronary artery disease	6.4e-05	0.00038	CcSEcCtD
Ceftriaxone—Urticaria—Timolol—coronary artery disease	6.38e-05	0.000379	CcSEcCtD
Ceftriaxone—Pain—Lisinopril—coronary artery disease	6.37e-05	0.000378	CcSEcCtD
Ceftriaxone—Abdominal pain—Timolol—coronary artery disease	6.35e-05	0.000377	CcSEcCtD
Ceftriaxone—Body temperature increased—Timolol—coronary artery disease	6.35e-05	0.000377	CcSEcCtD
Ceftriaxone—Dizziness—Losartan—coronary artery disease	6.34e-05	0.000376	CcSEcCtD
Ceftriaxone—Vomiting—Furosemide—coronary artery disease	6.32e-05	0.000375	CcSEcCtD
Ceftriaxone—Rash—Furosemide—coronary artery disease	6.26e-05	0.000372	CcSEcCtD
Ceftriaxone—Dermatitis—Furosemide—coronary artery disease	6.26e-05	0.000371	CcSEcCtD
Ceftriaxone—Nausea—Captopril—coronary artery disease	6.25e-05	0.000371	CcSEcCtD
Ceftriaxone—Headache—Furosemide—coronary artery disease	6.22e-05	0.000369	CcSEcCtD
Ceftriaxone—Feeling abnormal—Lisinopril—coronary artery disease	6.14e-05	0.000364	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Lisinopril—coronary artery disease	6.09e-05	0.000362	CcSEcCtD
Ceftriaxone—Vomiting—Losartan—coronary artery disease	6.09e-05	0.000362	CcSEcCtD
Ceftriaxone—Nausea—Perindopril—coronary artery disease	6.07e-05	0.00036	CcSEcCtD
Ceftriaxone—Hypersensitivity—Ramipril—coronary artery disease	6.05e-05	0.000359	CcSEcCtD
Ceftriaxone—Rash—Losartan—coronary artery disease	6.04e-05	0.000359	CcSEcCtD
Ceftriaxone—Dermatitis—Losartan—coronary artery disease	6.04e-05	0.000358	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—coronary artery disease	6.01e-05	0.0363	CrCbGaD
Ceftriaxone—Headache—Losartan—coronary artery disease	6e-05	0.000356	CcSEcCtD
Ceftriaxone—Urticaria—Lisinopril—coronary artery disease	5.92e-05	0.000351	CcSEcCtD
Ceftriaxone—Hypersensitivity—Timolol—coronary artery disease	5.92e-05	0.000351	CcSEcCtD
Ceftriaxone—Nausea—Furosemide—coronary artery disease	5.9e-05	0.00035	CcSEcCtD
Ceftriaxone—Abdominal pain—Lisinopril—coronary artery disease	5.89e-05	0.00035	CcSEcCtD
Ceftriaxone—Body temperature increased—Lisinopril—coronary artery disease	5.89e-05	0.00035	CcSEcCtD
Ceftriaxone—Pruritus—Ramipril—coronary artery disease	5.81e-05	0.000345	CcSEcCtD
Ceftriaxone—Nausea—Losartan—coronary artery disease	5.69e-05	0.000338	CcSEcCtD
Ceftriaxone—Pruritus—Timolol—coronary artery disease	5.68e-05	0.000337	CcSEcCtD
Ceftriaxone—Diarrhoea—Ramipril—coronary artery disease	5.62e-05	0.000334	CcSEcCtD
Ceftriaxone—Diarrhoea—Timolol—coronary artery disease	5.5e-05	0.000326	CcSEcCtD
Ceftriaxone—Hypersensitivity—Lisinopril—coronary artery disease	5.49e-05	0.000326	CcSEcCtD
Ceftriaxone—Dizziness—Ramipril—coronary artery disease	5.43e-05	0.000322	CcSEcCtD
Ceftriaxone—Dizziness—Timolol—coronary artery disease	5.31e-05	0.000315	CcSEcCtD
Ceftriaxone—Pruritus—Lisinopril—coronary artery disease	5.27e-05	0.000313	CcSEcCtD
Ceftriaxone—Vomiting—Ramipril—coronary artery disease	5.23e-05	0.00031	CcSEcCtD
Ceftriaxone—Rash—Ramipril—coronary artery disease	5.18e-05	0.000307	CcSEcCtD
Ceftriaxone—Dermatitis—Ramipril—coronary artery disease	5.18e-05	0.000307	CcSEcCtD
Ceftriaxone—Headache—Ramipril—coronary artery disease	5.15e-05	0.000305	CcSEcCtD
Ceftriaxone—Vomiting—Timolol—coronary artery disease	5.11e-05	0.000303	CcSEcCtD
Ceftriaxone—Diarrhoea—Lisinopril—coronary artery disease	5.1e-05	0.000303	CcSEcCtD
Ceftriaxone—Rash—Timolol—coronary artery disease	5.07e-05	0.000301	CcSEcCtD
Ceftriaxone—Dermatitis—Timolol—coronary artery disease	5.06e-05	0.0003	CcSEcCtD
Ceftriaxone—Headache—Timolol—coronary artery disease	5.03e-05	0.000299	CcSEcCtD
Ceftriaxone—Dizziness—Lisinopril—coronary artery disease	4.93e-05	0.000292	CcSEcCtD
Ceftriaxone—Nausea—Ramipril—coronary artery disease	4.88e-05	0.00029	CcSEcCtD
Ceftriaxone—Nausea—Timolol—coronary artery disease	4.77e-05	0.000283	CcSEcCtD
Ceftriaxone—Vomiting—Lisinopril—coronary artery disease	4.74e-05	0.000281	CcSEcCtD
Ceftriaxone—Rash—Lisinopril—coronary artery disease	4.7e-05	0.000279	CcSEcCtD
Ceftriaxone—Dermatitis—Lisinopril—coronary artery disease	4.7e-05	0.000279	CcSEcCtD
Ceftriaxone—Headache—Lisinopril—coronary artery disease	4.67e-05	0.000277	CcSEcCtD
Ceftriaxone—Nausea—Lisinopril—coronary artery disease	4.43e-05	0.000263	CcSEcCtD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	2.19e-05	0.000356	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SLC8A1—coronary artery disease	2.19e-05	0.000355	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GATA4—coronary artery disease	2.17e-05	0.000351	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AGT—coronary artery disease	2.16e-05	0.00035	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOB—coronary artery disease	2.14e-05	0.000347	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	2.13e-05	0.000345	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	2.13e-05	0.000345	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOE—coronary artery disease	2.12e-05	0.000343	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOA1—coronary artery disease	2.09e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—coronary artery disease	2.09e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	2.06e-05	0.000333	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	2.06e-05	0.000333	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.06e-05	0.000333	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—P2RY12—coronary artery disease	2.05e-05	0.000332	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—coronary artery disease	2.03e-05	0.000329	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—coronary artery disease	2.03e-05	0.000329	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—HGF—coronary artery disease	2.03e-05	0.000329	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLG—coronary artery disease	2.02e-05	0.000328	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	2.02e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	2.02e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	2.02e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—coronary artery disease	2.01e-05	0.000326	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CSF2—coronary artery disease	2.01e-05	0.000325	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	2e-05	0.000323	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	2e-05	0.000323	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GNA12—coronary artery disease	1.99e-05	0.000322	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—THBD—coronary artery disease	1.99e-05	0.000322	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	1.97e-05	0.000319	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—coronary artery disease	1.93e-05	0.000313	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	1.93e-05	0.000312	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—ITGB3—coronary artery disease	1.92e-05	0.000311	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.91e-05	0.000309	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HK1—coronary artery disease	1.9e-05	0.000307	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.9e-05	0.000307	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.9e-05	0.000307	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CD36—coronary artery disease	1.89e-05	0.000306	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPAP2B—coronary artery disease	1.89e-05	0.000306	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UQCRFS1—coronary artery disease	1.89e-05	0.000306	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CKM—coronary artery disease	1.89e-05	0.000306	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SELE—coronary artery disease	1.89e-05	0.000306	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.87e-05	0.000303	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TGFB1—coronary artery disease	1.86e-05	0.000302	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	1.85e-05	0.000299	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARG—coronary artery disease	1.84e-05	0.000299	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCD—coronary artery disease	1.83e-05	0.000297	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ALDOA—coronary artery disease	1.83e-05	0.000296	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—POMC—coronary artery disease	1.82e-05	0.000295	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	1.81e-05	0.000293	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOB—coronary artery disease	1.79e-05	0.00029	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	1.78e-05	0.000288	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—coronary artery disease	1.78e-05	0.000288	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—coronary artery disease	1.76e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CKMT2—coronary artery disease	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PYGM—coronary artery disease	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH6A1—coronary artery disease	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PDK4—coronary artery disease	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SULT4A1—coronary artery disease	1.76e-05	0.000285	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CRK—coronary artery disease	1.7e-05	0.000276	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.7e-05	0.000275	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SH2B3—coronary artery disease	1.68e-05	0.000272	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VWF—coronary artery disease	1.68e-05	0.000272	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ATP2A2—coronary artery disease	1.68e-05	0.000272	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—coronary artery disease	1.66e-05	0.000269	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APOA1—coronary artery disease	1.65e-05	0.000267	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—coronary artery disease	1.64e-05	0.000265	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—coronary artery disease	1.63e-05	0.000264	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK14—coronary artery disease	1.62e-05	0.000263	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—coronary artery disease	1.61e-05	0.000261	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SPARC—coronary artery disease	1.6e-05	0.00026	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F7—coronary artery disease	1.6e-05	0.00026	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F2R—coronary artery disease	1.6e-05	0.00026	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—coronary artery disease	1.59e-05	0.000257	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—F2—coronary artery disease	1.57e-05	0.000255	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—FN1—coronary artery disease	1.57e-05	0.000255	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IRF1—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FGB—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PFKM—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LDHA—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GK—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GYG1—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMGCS2—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GATM—coronary artery disease	1.57e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB2—coronary artery disease	1.54e-05	0.000249	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	1.53e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	1.53e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	1.53e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—THBS1—coronary artery disease	1.53e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	1.52e-05	0.000246	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	1.51e-05	0.000245	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.51e-05	0.000245	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AK1—coronary artery disease	1.49e-05	0.000242	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCH1—coronary artery disease	1.49e-05	0.000242	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	1.48e-05	0.000239	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	1.46e-05	0.000237	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.46e-05	0.000236	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—coronary artery disease	1.45e-05	0.000235	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLCD1—coronary artery disease	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UGCG—coronary artery disease	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MDH2—coronary artery disease	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPAT—coronary artery disease	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAT—coronary artery disease	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TIMP1—coronary artery disease	1.43e-05	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.42e-05	0.00023	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.42e-05	0.000229	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CETP—coronary artery disease	1.4e-05	0.000227	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PGM1—coronary artery disease	1.38e-05	0.000223	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF1—coronary artery disease	1.38e-05	0.000223	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.35e-05	0.000218	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—coronary artery disease	1.34e-05	0.000218	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.34e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PYGB—coronary artery disease	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CKB—coronary artery disease	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.33e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—coronary artery disease	1.31e-05	0.000212	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—coronary artery disease	1.3e-05	0.000211	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGAV—coronary artery disease	1.26e-05	0.000204	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KNG1—coronary artery disease	1.25e-05	0.000203	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COX5B—coronary artery disease	1.25e-05	0.000203	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLIN1—coronary artery disease	1.25e-05	0.000203	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DLAT—coronary artery disease	1.25e-05	0.000203	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PFKFB3—coronary artery disease	1.25e-05	0.000203	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM2—coronary artery disease	1.25e-05	0.000203	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAUR—coronary artery disease	1.24e-05	0.000201	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLAT—coronary artery disease	1.24e-05	0.0002	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IFNA2—coronary artery disease	1.23e-05	0.000199	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLG—coronary artery disease	1.22e-05	0.000197	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—JAK2—coronary artery disease	1.21e-05	0.000197	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.19e-05	0.000193	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SULT1E1—coronary artery disease	1.19e-05	0.000192	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCE—coronary artery disease	1.17e-05	0.000189	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SOD1—coronary artery disease	1.17e-05	0.000189	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.15e-05	0.000187	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HK2—coronary artery disease	1.13e-05	0.000183	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKR1B1—coronary artery disease	1.13e-05	0.000183	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—coronary artery disease	1.12e-05	0.000182	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC27A1—coronary artery disease	1.09e-05	0.000176	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOB—coronary artery disease	1.07e-05	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CPT1B—coronary artery disease	1.06e-05	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LCAT—coronary artery disease	1.06e-05	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	1.05e-05	0.00017	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HGF—coronary artery disease	1.05e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA4—coronary artery disease	1.04e-05	0.000169	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CSF2—coronary artery disease	1.03e-05	0.000167	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.03e-05	0.000166	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PDHA1—coronary artery disease	1.01e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCLM—coronary artery disease	1.01e-05	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGB3—coronary artery disease	9.91e-06	0.000161	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	9.78e-06	0.000158	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP11B2—coronary artery disease	9.77e-06	0.000158	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TXNRD1—coronary artery disease	9.77e-06	0.000158	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD36—coronary artery disease	9.75e-06	0.000158	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	9.71e-06	0.000157	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC22A3—coronary artery disease	9.63e-06	0.000156	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPP2CA—coronary artery disease	9.63e-06	0.000156	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ARNTL—coronary artery disease	9.49e-06	0.000154	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HADH—coronary artery disease	9.49e-06	0.000154	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCD—coronary artery disease	9.45e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	9.34e-06	0.000151	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	9.3e-06	0.000151	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	9.11e-06	0.000148	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	9.01e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G2A—coronary artery disease	8.99e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA2—coronary artery disease	8.99e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX2—coronary artery disease	8.99e-06	0.000146	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CA—coronary artery disease	8.92e-06	0.000145	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MMP1—coronary artery disease	8.89e-06	0.000144	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SULT1A1—coronary artery disease	8.88e-06	0.000144	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG5—coronary artery disease	8.88e-06	0.000144	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX4—coronary artery disease	8.88e-06	0.000144	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HK1—coronary artery disease	8.88e-06	0.000144	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.88e-06	0.000144	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HADHA—coronary artery disease	8.78e-06	0.000142	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAU—coronary artery disease	8.72e-06	0.000141	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTA1—coronary artery disease	8.68e-06	0.000141	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPA—coronary artery disease	8.58e-06	0.000139	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOA1—coronary artery disease	8.5e-06	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK14—coronary artery disease	8.37e-06	0.000136	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLCB3—coronary artery disease	8.31e-06	0.000135	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	8.27e-06	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA5—coronary artery disease	8.23e-06	0.000133	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F2—coronary artery disease	8.11e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FN1—coronary artery disease	8.11e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	8.11e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—P4HB—coronary artery disease	8.07e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS2—coronary artery disease	8.01e-06	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.99e-06	0.000129	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G1B—coronary artery disease	7.92e-06	0.000128	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.83e-06	0.000127	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.74e-06	0.000125	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—VCAN—coronary artery disease	7.46e-06	0.000121	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDOA—coronary artery disease	7.41e-06	0.00012	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	7.36e-06	0.000119	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—coronary artery disease	7.29e-06	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DCN—coronary artery disease	7.19e-06	0.000117	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF1—coronary artery disease	7.11e-06	0.000115	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	7.03e-06	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH2—coronary artery disease	7e-06	0.000113	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.82e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LIPC—coronary artery disease	6.82e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HBA1—coronary artery disease	6.82e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3C2A—coronary artery disease	6.82e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2C19—coronary artery disease	6.82e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOC3—coronary artery disease	6.77e-06	0.00011	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINE1—coronary artery disease	6.75e-06	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LDLR—coronary artery disease	6.73e-06	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.73e-06	0.000109	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC9A1—coronary artery disease	6.65e-06	0.000108	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTT1—coronary artery disease	6.65e-06	0.000108	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCLC—coronary artery disease	6.58e-06	0.000107	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CETP—coronary artery disease	6.58e-06	0.000107	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SDC1—coronary artery disease	6.5e-06	0.000105	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—coronary artery disease	6.44e-06	0.000104	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—JAK2—coronary artery disease	6.26e-06	0.000101	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PSMA6—coronary artery disease	6.14e-06	9.95e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PSMB5—coronary artery disease	6.14e-06	9.95e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CTGF—coronary artery disease	6e-06	9.72e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GOT2—coronary artery disease	5.95e-06	9.64e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMGCR—coronary artery disease	5.95e-06	9.64e-05	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	5.75e-06	9.31e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLCB1—coronary artery disease	5.47e-06	8.86e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.36e-06	8.69e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCA1—coronary artery disease	5.3e-06	8.59e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GGT1—coronary artery disease	5.13e-06	8.32e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GOT1—coronary artery disease	5.13e-06	8.32e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—coronary artery disease	4.64e-06	7.52e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTP1—coronary artery disease	4.61e-06	7.47e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARGC1A—coronary artery disease	4.57e-06	7.4e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—coronary artery disease	4.55e-06	7.37e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAT—coronary artery disease	4.49e-06	7.27e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOB—coronary artery disease	4.36e-06	7.06e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB1—coronary artery disease	4.26e-06	6.9e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM1—coronary artery disease	4.24e-06	6.87e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK1—coronary artery disease	4.18e-06	6.77e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPL—coronary artery disease	4.16e-06	6.74e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX1—coronary artery disease	4.06e-06	6.58e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CD36—coronary artery disease	3.95e-06	6.4e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPP2CA—coronary artery disease	3.9e-06	6.32e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTHFR—coronary artery disease	3.75e-06	6.07e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CA—coronary artery disease	3.63e-06	5.87e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AGT—coronary artery disease	3.56e-06	5.77e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—coronary artery disease	3.49e-06	5.65e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA1—coronary artery disease	3.45e-06	5.58e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.3e-06	5.35e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARG—coronary artery disease	3.04e-06	4.92e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—POMC—coronary artery disease	3e-06	4.85e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—coronary artery disease	2.96e-06	4.8e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—coronary artery disease	2.61e-06	4.23e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—coronary artery disease	2.39e-06	3.87e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CA—coronary artery disease	1.47e-06	2.38e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—coronary artery disease	1.2e-06	1.95e-05	CbGpPWpGaD
